Hostname: page-component-77c89778f8-vpsfw Total loading time: 0 Render date: 2024-07-20T00:06:39.533Z Has data issue: false hasContentIssue false
  • English
  • Français

Surveillance of Hemodialysis-Associated Primary Bloodstream Infections: The Experience of Ten Hospital-Based Centers

Published online by Cambridge University Press:  02 January 2015

Margaret Dopirak ,
Connie Hill ,
Marylee Oleksiw ,
Diane Dumigan ,
Jean Arvai ,
Ellen English ,
Evelyn Carusillo ,
Susan Malo-Schlegel ,
Jeana Richo  and
Karen Traficanti
...Show all authors
Margaret Dopirak
Affiliation:
Hartford Hospital, Hartford, Connecticut
Connie Hill
Affiliation:
ESRD Network of New England, New Haven, Connecticut
Marylee Oleksiw*
Affiliation:
Middlesex Hospital, Middletown, Connecticut
Diane Dumigan
Affiliation:
Hospital of St. Raphael, New Haven, Connecticut
Jean Arvai
Affiliation:
New Britain General Hospital, New Britain, Connecticut
Ellen English
Affiliation:
Rockville General Hospital, Rockville, Connecticut
Evelyn Carusillo
Affiliation:
Charlotte Hungerford Hospital, Torrington, Connecticut
Susan Malo-Schlegel
Affiliation:
Hartford Hospital, Hartford, Connecticut
Jeana Richo
Affiliation:
VA Connecticut Healthcare System, West Haven, Connecticut
Karen Traficanti
Affiliation:
Rockville General Hospital, Rockville, Connecticut
Bobbie Welch
Affiliation:
Danbury Hospital, Danbury, Connecticut
Brian Cooper
Affiliation:
University of Connecticut, Farmington, Connecticut
*
Middlesex Hospital, 28 Crescent Street, Middletown, CT 06457
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To determine baseline rates of primary bloodstream infection (BSI) among a large pool of patients receiving hemodialysis using standardized surveillance tools and methodology.

Design:

Prospective, descriptive analysis of primary BSI rates.

Setting:

Ten hospital-based hemodialysis centers in Connecticut.

Patients:

All patients receiving long-term hemodialysis in the participating facilities.

Results:

A total of 158 BSIs occurred during 142,525 dialysis sessions within a 12-month study period. Of the BSIs, 15.2% occurred in patients with fistula or graft access and 84.8% in patients with central venous catheter access (P < .001). Rates per 100 patient-years in centers ranged from 0 to 30.8, with a mean of 16.6. Rates per 1,000 dialysis sessions ranged from 0 to 2.1, with a mean of 1.1. Coagulase-negative staphylococci and Staphylococcus aureus (including methicillin-resistant S. aureus) accounted for 61% and Klebsiella or Enterobacter species for 14.6% of infections. Of the patients, 63.3% received vancomycin, 24.7% received cefazolin, and 41.7% received aminoglycosides. Rates declined in the second 6 months of the study from 1.4 to 0.8 infections per 1,000 dialysis sessions (P < .001).

Conclusions:

Primary BSI rates varied widely among participating centers and declined during the study period. BSIs were strongly associated with central venous catheter access. Further studies are needed to determine the reasons for variance in rates between centers and among various types of hemodialysis access.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 23 , Issue 12 , December 2002 , pp. 721 - 724
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.U.S. Renal Data System. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. Am J Kidney Dis 1997;30(2 suppl 1):S160–S177.CrossRefGoogle Scholar
2.USRDS Coordinating Center. 1999 Annual Data Report. Bethesda, MD: National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 1999:90–91.Google Scholar
3.Feldman, HI, Held, PJ, Hutchinson, JT, Stoiber, E, Hartigan, MF, Berlin, JA. Hemodialysis vascular access morbidity in the United States. Kidney Int 1993;43:1091–1096.CrossRefGoogle ScholarPubMed
4.Hoen, B, Paul-Dauphin, A, Hestin, D, Kessler, M. EPIBACDIAL: a multi-center prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998;9:869–876.CrossRefGoogle Scholar
5.Tokars, JI, Miller, ER. National Surveillance of Dialysis-Associated Diseases in the United States, 1996. Atlanta, GA: National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, Department of Health and Human Services; 1996.Google Scholar
6.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.CrossRefGoogle ScholarPubMed
7.Trick, WE, Fridkin, K, Edwards, JR, Gaynes, RP. Trends in primary bloodstream infections associated with Candida spp in the United States. Presented at the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections; March 5-9, 2000; Atlanta, GA.Google Scholar
8.Weinstein, MP. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis 1996;23: 40–46.CrossRefGoogle ScholarPubMed
9.Keane, WF, Collins, AJ. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 1994; 24:1010–1018.CrossRefGoogle ScholarPubMed
10.Beddhu, S, Bruns, FJ, Saul, M, Seddon, P, Zeidel, ML. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000;108:609–613.CrossRefGoogle ScholarPubMed